First Baby Vaccine for Womb Application Approved for Respiratory Syncytial Virus Disease Prevention

Medicine & Technology Aug 22, 2023

Previously, Abrysvo gained approval for use on individuals aged 60 and up to combat RSV. Read to learn more.

FDA Has Given the Green Light for the World's First RSV Vaccine To Prevent Common Virus From Causing Life-Threatening Illness

May 04, 2023

GSK's RSV vaccine has been approved by the US Food and Drug Administration (FDA) for individuals aged 60 and above, culminating in a quest spanning several decades.

Sanofi, GSK Seek FDA Clearance for New Vaccine Offering Strong Protection Against Severe Infection

Feb 23, 2022

Sanofi and GSK are releasing a new COVID-19 vaccine. Read more to know how this new jab compares to existing vaccines.

New COVID-19 Vaccine on Phase 3 Trials: Sanofi, GSK Announce Involvement of 35,000 Participants

May 28, 2021

European drug manufacturers Sanofi and GlaxoSmithKline or GSK announced yesterday that they are launching large-scale clinical trials for their new COVID-19 vaccines.

GSK, Sanofi to Start Human Trials for Protein-Based COVID-19 Vaccine

Sep 03, 2020

Multinational pharma giants GlaxoSmithKline (GSK) and Sanofi are set to start the human trial phase of their protein-based COVID-19 vaccine.

Asthma Inhaler Recall: GSK Says Nearly 600,000 May Have Defect

Apr 11, 2017

Nearly 600,000 Asthma Inhalers Recalled Nationwide Over ‘Defective Delivery System.